Decheng Capital LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$573.2B
Holdings
23
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (23 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 6,371,669 | $256.7B | 44.78% | |
| 2 | NUVBNuvation Bio Inc. | 25,954,439 | $96.0B | 16.75% | |
| 3 | UPBUpstream Bio Inc. | 3,285,293 | $61.8B | 10.78% | |
| 4 | AARDAARDVARK THERAPEUTICS INC | 3,917,299 | $52.1B | 9.08% | |
| 5 | NAMSNEWAMSTERDAM PHARMA CO NV | 657,051 | $18.7B | 3.26% | |
| 6 | MRUSMERUS NV | 186,546 | $17.6B | 3.06% | |
| 7 | RVMDREVOLUTION MEDICINES INC(NSM) | 210,000 | $9.8B | 1.71% | |
| 8 | LYELLyell Immunopharma, Inc. | 595,466 | $9.7B | 1.69% | |
| 9 | BYSIBeyondSpring Inc. | 4,286,104 | $7.8B | 1.35% | |
| 10 | ACRSAclaris Therapeutics, Inc. | 4,041,736 | $7.7B | 1.34% | |
| 11 | RCUSArcus Biosciences, Inc | 547,609 | $7.4B | 1.30% | |
| 12 | EQEquillium Inc. | 4,447,308 | $6.4B | 1.11% | |
| 13 | CRNXCRINETICS PHARMACEUTICALS IN | 143,000 | $6.0B | 1.04% | |
| 14 | KRYSKRYSTAL BIOTECH INC | 32,300 | $5.7B | 0.99% | |
| 15 | AURAAura Biosciences, Inc. | 515,555 | $3.2B | 0.56% | |
| 16 | ZNTLZentalis Pharmaceuticals Inc. | 1,323,327 | $2.0B | 0.35% | |
| 17 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 181,600 | $1.3B | 0.23% | |
| 18 | FDMT4D MOLECULAR THERAPEUTICS IN | 92,748 | $806.0M | 0.14% | |
| 19 | ILMNIllumnia, Inc. | 7,979 | $757.8M | 0.13% | |
| 20 | PYXSPyxis Oncology, Inc (formerly Apexigen) | 326,810 | $725.5M | 0.13% | |
| 21 | GRALGRAIL INC | 9,684 | $572.6M | 0.10% | |
| 22 | RZLTREZOLUTE INC | 59,900 | $563.1M | 0.10% | |
| 23 | NUVB/WSNuvation Bio Inc. | 646,057 | $115.5M | 0.02% |